<DOC>
	<DOCNO>NCT01349465</DOCNO>
	<brief_summary>The purpose study investigate durability SVR chronic HCV patient achieve SVR previous study TMC435-containing regimen time resistance associate mutation return baseline chronic HCV patient achieve SVR previous study TMC435-containing regimen .</brief_summary>
	<brief_title>3-year Follow-up Study Patients Previously Treated With TMC435-Containing Regimen Treatment Hepatitis C Virus Infection</brief_title>
	<detailed_description>This 3-year follow-up study patient complete last post-therapy follow-up visit previous Phase IIb [ NCT00882908 , NCT00980330 ] Phase III [ NCT01289782 , NCT01290679 , NCT01281839 ] study receive TMC435 , combination pegylated interferon ribavirin , treatment hepatitis C infection . The entire study duration patient approximately 36 month . The medical follow-up patient perform accord local standard care . This study evaluate level hepatitis C virus blood circulation , well safety alpha-fetoprotein test change sequence HCV NS3/4A region time patient confirm detectable HCV RNA last post-therapy follow-up visit previous TMC435 study . In study development liver disease progression also assess . No medication administer study .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<criteria>Have previously participate Phase IIb Phase III study Must receive least one dose TMC435 study Has complete last posttherapy followup visit previous ( LPVPS ) study Must currently enrol plan enroll another study investigational drug invasive investigational medical device Have receive antiviral immunomodulating treatment , include therapeutic vaccine , hepatitis C virus ( HCV ) LPVPS screen visit present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>Hepatitis</keyword>
	<keyword>TMC435</keyword>
	<keyword>Liver disease</keyword>
	<keyword>Virus Infection</keyword>
</DOC>